Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...
Hosted on MSN12h
Ozempic may block intestines, FDA warns with new label(NewsNation) — Diabetes and popular weight-loss drug Ozempic might block intestines in some patients who use the medication, an updated label from the U.S. Food and Drug Administration warns. The FDA ...
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
Experts are now concerned that patients with Ozempic prescriptions will try to microdose at home, which could cause an ...
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
Researchers attempt to identify 15 Medicare Part D drugs with the highest risk of facing the U.S. government's ...
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
A new study published in JAMA Network Open contends that women may lose more weight on semaglutides like Ozempic than men.
The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.
People are seeking out 'microdoses' of Ozempic and other weight-loss drugs. Medical professionals say there's pros and cons.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback